• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgA 肾病患者肾脏中增强的 Bruton 酪氨酸激酶活性。

Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.

机构信息

Department of Nephrology, The First Affiliated Hospital, Anhui Medical University, No. 218, Jixi Road, Hefei, Anhui, 230032, People's Republic of China.

出版信息

Int Urol Nephrol. 2021 Jul;53(7):1399-1415. doi: 10.1007/s11255-020-02733-2. Epub 2021 Jan 3.

DOI:10.1007/s11255-020-02733-2
PMID:33389462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8192408/
Abstract

PURPOSE

Bruton's tyrosine kinase (BTK) is a vital biological molecule that contributes to immune regulation. Previous studies have showed that BTK can be detected in patients with lupus nephritis and rheumatoid arthritis. However, the role of BTK in IgA nephropathy (IgAN) has not yet been elucidated. The purpose of this research was to investigate the role of BTK activation in macrophages in IgAN.

METHODS

Peripheral blood and renal tissue samples were collected from 63 patients with IgAN, and peritumoral normal tissues were collected from 20 patients after surgical resection of renal tumor for use as control. Additionally, 20 healthy volunteers were recruited as control. The levels of BTK, CD68, phosphorylated BTK (pBTK), phosphorylated NF-κB (p-NF-κB p65), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and monocyte chemotactic protein (MCP)-1 were measured by immunohistochemistry (IHC), real-time polymerase chain reaction (RT-PCR), western blotting, and enzyme-linked immunosorbent assay (ELISA).

RESULTS

Compared to peritumoral normal tissues, the expression levels of CD68 and BTK were significantly increased in IgAN group (p < 0.001) and the differences between M0 and M1, E0 and E1, S0 and S1, T0 and T1-2, C0 and C1-2 were statistically significant in the updated Oxford Classification (p < 0.05). Also, CD68 and BTK were positively correlated with Katafuchi semi-quantitative glomerular and tubulointerstitial scores (r = 0.580, 0.637 and 0.442, 0.489, respectively, p < 0.05). The expression of BTK was significantly higher in C3b- and C4d-positive renal tissues of patients with IgAN (p < 0.05). In addition, BTK was positively correlated with 24-h urine protein, serum creatinine levels (r = 0.456 and 0.453, respectively, p < 0.001), and negatively correlated with serum albumin (r = 0.357, p < 0.05). The intensity of expression of pBTK and p-NF-κB p65 was observably increased in renal tissues and monocytes of patients with IgAN compared to the control group. The results of IHC, RT-PCR, and ELISA indicated that the levels of TNF-ɑ, IL-1β, and MCP-1 were markedly increased in the IgAN group (p < 0.05).

CONCLUSION

The results of this study indicate that activation of BTK in macrophages may play an important role in promoting the progression of renal inflammation in IgAN.

摘要

目的

布鲁顿酪氨酸激酶(BTK)是一种重要的生物分子,参与免疫调节。先前的研究表明,BTK 可在狼疮肾炎和类风湿关节炎患者中检测到。然而,BTK 在 IgA 肾病(IgAN)中的作用尚未阐明。本研究旨在探讨 BTK 在 IgAN 中巨噬细胞中的激活作用。

方法

收集 63 例 IgAN 患者的外周血和肾组织样本,收集 20 例肾肿瘤切除术后肿瘤旁正常组织作为对照。此外,招募 20 名健康志愿者作为对照。采用免疫组化(IHC)、实时聚合酶链反应(RT-PCR)、Western blot 和酶联免疫吸附试验(ELISA)检测 BTK、CD68、磷酸化 BTK(pBTK)、磷酸化核因子-κB(p-NF-κB p65)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β和单核细胞趋化蛋白(MCP)-1的水平。

结果

与肿瘤旁正常组织相比,IgAN 组 CD68 和 BTK 的表达水平显著升高(p<0.001),在更新的牛津分类中,M0 与 M1、E0 与 E1、S0 与 S1、T0 与 T1-2、C0 与 C1-2 之间的差异具有统计学意义(p<0.05)。此外,CD68 和 BTK 与 Katafuchi 半定量肾小球和肾小管间质评分呈正相关(r=0.580、0.637 和 0.442、0.489,p<0.05)。BTK 在 IgAN 患者 C3b 和 C4d 阳性肾组织中的表达明显升高(p<0.05)。此外,BTK 与 24 小时尿蛋白、血清肌酐水平呈正相关(r=0.456 和 0.453,p<0.001),与血清白蛋白呈负相关(r=0.357,p<0.05)。与对照组相比,IgAN 患者肾组织和单核细胞中 pBTK 和 p-NF-κB p65 的表达强度明显增加。IHC、RT-PCR 和 ELISA 的结果表明,IgAN 组 TNF-ɑ、IL-1β 和 MCP-1 的水平明显升高(p<0.05)。

结论

本研究结果表明,BTK 在巨噬细胞中的激活可能在促进 IgAN 肾炎症进展中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/220d1ca93ca9/11255_2020_2733_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/1bc881c6f442/11255_2020_2733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/410cbfcab698/11255_2020_2733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/89679eb95606/11255_2020_2733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/a67ed933913b/11255_2020_2733_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/392b69068de5/11255_2020_2733_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/4335b5be79e2/11255_2020_2733_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/8eb52ded76ba/11255_2020_2733_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/12fc3d940852/11255_2020_2733_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/b643caeceb59/11255_2020_2733_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/620a031d7d46/11255_2020_2733_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/78b02ec6bac6/11255_2020_2733_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/bcde1407d5fe/11255_2020_2733_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/220d1ca93ca9/11255_2020_2733_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/1bc881c6f442/11255_2020_2733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/410cbfcab698/11255_2020_2733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/89679eb95606/11255_2020_2733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/a67ed933913b/11255_2020_2733_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/392b69068de5/11255_2020_2733_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/4335b5be79e2/11255_2020_2733_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/8eb52ded76ba/11255_2020_2733_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/12fc3d940852/11255_2020_2733_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/b643caeceb59/11255_2020_2733_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/620a031d7d46/11255_2020_2733_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/78b02ec6bac6/11255_2020_2733_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/bcde1407d5fe/11255_2020_2733_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0067/8192408/220d1ca93ca9/11255_2020_2733_Fig13_HTML.jpg

相似文献

1
Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy.IgA 肾病患者肾脏中增强的 Bruton 酪氨酸激酶活性。
Int Urol Nephrol. 2021 Jul;53(7):1399-1415. doi: 10.1007/s11255-020-02733-2. Epub 2021 Jan 3.
2
Increased Tim-3 monocytes/macrophages are associated with disease severity in patients with IgA nephropathy.Tim-3 阳性单核细胞/巨噬细胞增多与 IgA 肾病患者的疾病严重程度相关。
Int Immunopharmacol. 2021 Aug;97:107666. doi: 10.1016/j.intimp.2021.107666. Epub 2021 May 28.
3
Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.伊布替尼(一种选择性布鲁顿酪氨酸激酶抑制剂)对格雷夫斯眼病患者眼眶成纤维细胞的治疗作用。
PLoS One. 2022 Dec 15;17(12):e0279060. doi: 10.1371/journal.pone.0279060. eCollection 2022.
4
Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages.布鲁顿酪氨酸激酶抑制剂 PCI-32765 可降低高糖诱导的巨噬细胞中促炎介质的产生。
Int Immunopharmacol. 2018 May;58:145-153. doi: 10.1016/j.intimp.2018.03.019. Epub 2018 Mar 26.
5
Plasma Gelsolin Promotes Proliferation of Mesangial Cell in IgA Nephropathy.血浆凝溶胶蛋白促进IgA肾病中系膜细胞的增殖。
Cell Physiol Biochem. 2016;40(6):1473-1486. doi: 10.1159/000453199. Epub 2016 Dec 20.
6
Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.炎症反应期间IgA肾病中TLR4与Notch1信号通路之间的相互作用。
Int Urol Nephrol. 2018 Apr;50(4):779-785. doi: 10.1007/s11255-017-1760-2. Epub 2017 Dec 11.
7
Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.外周血中布鲁顿酪氨酸激酶表达增加与狼疮肾炎有关。
Clin Rheumatol. 2018 Jan;37(1):43-49. doi: 10.1007/s10067-017-3717-3. Epub 2017 Jun 14.
8
Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.IgA 肾病患者的肿瘤坏死因子-α 血清水平与疾病严重程度密切相关。
BMC Nephrol. 2018 Nov 14;19(1):326. doi: 10.1186/s12882-018-1069-0.
9
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.布鲁顿酪氨酸激酶抑制减轻盲肠结扎穿刺术诱导的小鼠心功能障碍。
Front Immunol. 2019 Sep 6;10:2129. doi: 10.3389/fimmu.2019.02129. eCollection 2019.
10
[Regulation of Chrysophanol-mediated TLR4/NF-κB Pathway on Renal Injury and Immune Response in IgA Nephropathy Rats].[大黄酚介导的TLR4/NF-κB信号通路对IgA肾病大鼠肾损伤及免疫反应的调控作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 Dec;50(6):840-846.

引用本文的文献

1
Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.伊布替尼(一种选择性布鲁顿酪氨酸激酶抑制剂)对格雷夫斯眼病患者眼眶成纤维细胞的治疗作用。
PLoS One. 2022 Dec 15;17(12):e0279060. doi: 10.1371/journal.pone.0279060. eCollection 2022.
2
Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.抑制布鲁顿酪氨酸激酶活性可减轻大鼠失血性休克诱导的多器官功能障碍。
Ann Surg. 2023 Mar 1;277(3):e624-e633. doi: 10.1097/SLA.0000000000005357. Epub 2021 Dec 27.
3
Bruton's tyrosine kinase regulates macrophage‑induced inflammation in the diabetic kidney via NLRP3 inflammasome activation.

本文引用的文献

1
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis.浆细胞和 B 细胞在化脓性汗腺炎发病机制中的作用。
JCI Insight. 2020 Oct 2;5(19):139930. doi: 10.1172/jci.insight.139930.
2
Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production.补体因子 H 调节脾脏 B 细胞发育并限制自身抗体产生。
Front Immunol. 2019 Jul 11;10:1607. doi: 10.3389/fimmu.2019.01607. eCollection 2019.
3
Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages.
布鲁顿酪氨酸激酶通过 NLRP3 炎性小体激活调节糖尿病肾脏中的巨噬细胞诱导的炎症。
Int J Mol Med. 2021 Sep;48(3). doi: 10.3892/ijmm.2021.5010. Epub 2021 Jul 19.
布鲁顿酪氨酸激酶抑制剂 PCI-32765 可降低高糖诱导的巨噬细胞中促炎介质的产生。
Int Immunopharmacol. 2018 May;58:145-153. doi: 10.1016/j.intimp.2018.03.019. Epub 2018 Mar 26.
4
Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.布鲁顿酪氨酸激酶:先天性免疫中一个新出现的关键角色。
Front Immunol. 2017 Nov 8;8:1454. doi: 10.3389/fimmu.2017.01454. eCollection 2017.
5
What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection.遗传学关于IgA肾病发病机制告诉了我们什么:免疫因素和感染的作用
Kidney Int Rep. 2017 Feb 14;2(3):318-331. doi: 10.1016/j.ekir.2017.02.005. eCollection 2017 May.
6
Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.外周血中布鲁顿酪氨酸激酶表达增加与狼疮肾炎有关。
Clin Rheumatol. 2018 Jan;37(1):43-49. doi: 10.1007/s10067-017-3717-3. Epub 2017 Jun 14.
7
Glomerular disease: Updated Oxford Classification of IgA nephropathy: a new MEST-C score.肾小球疾病:IgA肾病的牛津分类更新:一种新的MEST-C评分
Nat Rev Nephrol. 2017 Jul;13(7):385-386. doi: 10.1038/nrneph.2017.67. Epub 2017 May 22.
8
The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.布鲁顿酪氨酸激酶抑制剂依鲁替尼通过调节肿瘤浸润巨噬细胞发挥免疫调节作用。
Oncotarget. 2017 Jun 13;8(24):39218-39229. doi: 10.18632/oncotarget.16836.
9
IgA nephropathy.IgA 肾病。
Nat Rev Dis Primers. 2016 Feb 11;2:16001. doi: 10.1038/nrdp.2016.1.
10
Molecular Insights into the Pathogenesis of IgA Nephropathy.IgA 肾病发病机制的分子见解。
Trends Mol Med. 2015 Dec;21(12):762-775. doi: 10.1016/j.molmed.2015.10.003. Epub 2015 Nov 21.